EU drug regulator EMA records 415 cases of possible rare blood clotting

Reading Time: < 1 minute The EU drug regulator said on Thursday it has received reports of 415 possible cases of rare blood clotting with a low platelet count in the European Economic Area, out of more than 50 million people who have received AstraZeneca and Johnson & Johnson COVID-19 vaccines. There have been 10 possible cases among just under 6 million